	Therapeutic potentials of curcumin in prostate cancer: a comprehensive review of pathways and clinical prospects. Prostate Int Fattahi MR, Shoja F, Mojaradi MA, Nazarinezhad P, Dehghanbanadaki H, Arefnezhad R, Rezaei-Tazangi F, Azimi H. PMID: 42382546 [PubMed]
	Role of Postoperative Radiation Therapy After Radical Cystectomy for Bladder Cancer: A Systematic Review and Meta-Analysis. Adv Radiat Oncol Nohmi RL, Marques FC, Brito HC, Leite LM, Araujo DV. PMID: 42382432 [PubMed]
	Laparoscopic Versus Open Radical Nephrectomy for Renal Cell Carcinoma: A Retrospective Study. Indian J Surg Oncol Abouzid A, Shetiwy M, Hamdy M, Atallah K, Ezzat M, Elghaffar MA. PMID: 42381807 [PubMed]
	Correlation of Multiparametric MRI PIRADS Scoring with Histopathological Outcomes and Prognostic Significance in Prostate Cancer: A Tertiary Care Center Study. Indian J Surg Oncol R KJ, Charan NS, Ram CG, Mahendra S, Deepak B, S SA, Taruna Y, Meenakshi R. PMID: 42381792 [PubMed]
	Cardiovascular-Kidney-Metabolic Syndrome, Healthy Lifestyles, and Risk of Cancer Incidence and Mortality: AÂ Prospective Cohort Study. Int J Cancer Qie R, Liu H, Liu Y, Guo X, Chen Q, Xu H, Wang X, Kang R, Cheng C, Zhao M, Wang H, Zheng L, Liu S, Zhang S. PMID: 42381231 [PubMed - as supplied by publisher]
	Impact of hepatotoxicity and lipid metabolism-related toxicity on survival and quality of life in patients with high-volume metastatic hormone-sensitive prostate cancer treated with rezvilutamide in the CHART trial: a post hoc analysis. BMC Med Wu JL, Jiang SS, Luo H, Dong P, Wang ZJ, Xing NZ, Ma T, Wang ZP, Gu XQ, Zhou GC, Xue XY, Sun ZQ, Yang Y, Wang CX, Shan GY, Zhang AL, Ding DG, Wang LP, Duan XH, Wang TT, He T, Lin CY, Zhong XW, Lian JP, Wang WL, Ye DW, Dai B. PMID: 42380973 [PubMed - as supplied by publisher]
	Transurethral ultrasound ablation for prostate cancer: MRI-based pre-treatment planning and post-treatment assessment-what the radiologist needs to know. Abdom Radiol (NY) Takahashi S, Miura M, Higashiyama H. PMID: 42380349 [PubMed - as supplied by publisher]
	Re: Ultra-hypofractionated Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma: 5-year Outcomes from a Pooled Analysis of the FASTRACK Trials. Eur Urol Liu T, Zhu C, Yan Z. PMID: 42379927 [PubMed - as supplied by publisher]
	Re: Alexander D. Sherry, Van To, Criselle D'souza, et al. Metastasis-directed Therapy With or Without Pembrolizumab for Oligometastatic Clear Cell Renal Cell Carcinoma: Pooled Analysis of Two Prospective Single-arm Phase 2 Trials. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.03.024. Eur Urol Cigliola A, Necchi A, Capitanio U. PMID: 42379926 [PubMed - as supplied by publisher]
	Beyond the tumor: Recurrence-prone radiomics for prognostication in negative PSMA PET/CT scans of prostate cancer. Biomed Phys Eng Express Yousefirizi F, Harsini S, Mohebi M, Alberts I, Yusufaly T, Luo M, Abdollahi H, Yazdani E, Mirabedian S, Sabouri M, Geramifar P, Sheikhzadeh P, Martineau P, Wilson D, Bénard F, Uribe CF, Rahmim A. PMID: 42379193 [PubMed - as supplied by publisher]
	Clinically relevant endpoints and quality-of-life outcomes with darolutamide in patients with metastatic hormone-sensitive prostate cancer: Analyses of the phase III ARASENS trial. Eur J Cancer Fizazi K, Smith MR, Hussain M, Saad F, Sternberg CN, David Crawford E, Aragon-Ching JB, Schostak M, Tutrone R, Morgans AK, Sentana-Lledo D, Joensuu H, Mohamed AF, Littleton N, Srinivasan S, Buttkewitz Y, Li R, Kuss I, Tombal B. PMID: 42378957 [PubMed - as supplied by publisher]
	Association of Cumulative Proton Pump Inhibitor Use with Prostate Cancer Risk and Outcomes: A Population-Based Cohort Study. Cancer Res Commun Sayyid RK, Tiwari R, Zhang B, Wilton AS, Lajkosz K, Cockburn JG, Bernardino RM, Al-Daqqaq Z, Penn LZ, Goldberg H, Saskin R, Fleshner NE. PMID: 42378436 [PubMed - as supplied by publisher]
	Efficacy, safety, and treatment feasibility of pembrolizumab plus lenvatinib in patients aged 75 years or older with advanced renal cell carcinoma: a Japanese multicenter retrospective study. Int J Clin Oncol Yamashita S, Yamasaki T, Ueda K, Tomida R, Toyoda S, Iwamoto H, Miyake M, Tomisaki I, Morizane S, Kohjimoto Y. PMID: 42377813 [PubMed - as supplied by publisher]
	Angiotensin Converting Enzyme (ACE) insertion/deletion (rs1799752) gene polymorphism and bladder cancer aggressiveness in Egyptian patients: A pilot case-control study. Mol Biol Rep Atia N, Osman Y, Abdel-Aziz AF, Refaat S, Khalil MR, Refaat M. PMID: 42377753 [PubMed - indexed for MEDLINE]
	4D flow MRI for the evaluation of venous anatomy and flow in renal cell carcinoma with venous tumor thrombus: a pictorial essay. Abdom Radiol (NY) Wentland AL, García-Rodríguez S, Roadman DF, Wieben O, Ansari N, Shapiro DD, Abel EJ. PMID: 42377543 [PubMed - as supplied by publisher]
	(18)F-Fluciclovine or (68)Ga-PSMA-11 PET/CT-guided Salvage Radiotherapy Changes in Postprostatectomy Biochemical Recurrence: Secondary Analysis of the EMPIRE-2 Trial. Radiology Abiodun-Ojo OA, Jani AB, Goyal S, Lawal IO, Halkar RK, Dhere V, Shelton JW, Patel PR, Schreibmann E, Hershatter B, Patel SA, Hanasoge S, Sebastian NT, Schuster DM. PMID: 42377125 [PubMed - indexed for MEDLINE]
	Predictive biomarkers of response in metastatic prostate cancer: paving the way for a new era of precision medicine. Expert Rev Anticancer Ther Mercinelli C, Di Costanzo F, Oing C, Guandalini G, Maiorano BA, Sammarco E, Salfi A, Serafin D, Tateo V, Cigliola A, Piacentini M, Pastorino GL, Galli L, Conteduca V, Formisano L, Rescigno P, Necchi A. PMID: 42376796 [PubMed - as supplied by publisher]
	Common Bile Duct Diameter in Bladder Urothelial Carcinoma: A Case-Control Study. Cancer Manag Res Dadkhah A, Zolfaghari M, Bagheri SM, Soltani S, Fooladi Z, Emami M. PMID: 42376600 [PubMed]
	State of the nation: Understanding the current NHS treatment pathway to identify opportunities to advance future care of patients with high-risk non-muscle invasive bladder cancer in the UK (SPAN-UK). BJUI Compass Aning J, Catto JWF, Martin R, Chatterton K, Mariappan P, Ottley E, Hickey J, McCormack S, Gill S, Szabados B. PMID: 42375995 [PubMed]
	Prostate Cancer: Etiology, Diagnosis, and Treatment. Serican J Med Li C, Li Z, Liu X. PMID: 42375929 [PubMed]

Articles 1 - 20 / 179611

Page 1 of 8981



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy